- Home
- NSTS vs BRNS Comparison
NSTS vs BRNS Comparison
Compare NSTS & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSTS
- BRNS
- Stock Information
- Founded
- NSTS 1921
- BRNS 2016
- Country
- NSTS United States
- BRNS United Kingdom
- Employees
- NSTS N/A
- BRNS N/A
- Industry
- NSTS Savings Institutions
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- NSTS Finance
- BRNS Health Care
- Exchange
- NSTS Nasdaq
- BRNS Nasdaq
- Market Cap
- NSTS 65.5M
- BRNS 36.0M
- IPO Year
- NSTS N/A
- BRNS 2021
- Fundamental
- Price
- NSTS $11.80
- BRNS $2.02
- Analyst Decision
- NSTS
- BRNS Strong Buy
- Analyst Count
- NSTS 0
- BRNS 1
- Target Price
- NSTS N/A
- BRNS $3.00
- AVG Volume (30 Days)
- NSTS 4.5K
- BRNS 3.4M
- Earning Date
- NSTS 08-08-2025
- BRNS 08-07-2025
- Dividend Yield
- NSTS N/A
- BRNS N/A
- EPS Growth
- NSTS N/A
- BRNS N/A
- EPS
- NSTS N/A
- BRNS N/A
- Revenue
- NSTS $9,115,000.00
- BRNS $14,969,000.00
- Revenue This Year
- NSTS N/A
- BRNS N/A
- Revenue Next Year
- NSTS N/A
- BRNS N/A
- P/E Ratio
- NSTS N/A
- BRNS N/A
- Revenue Growth
- NSTS 78.72
- BRNS 4381.74
- 52 Week Low
- NSTS $9.37
- BRNS $0.64
- 52 Week High
- NSTS $13.32
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- NSTS 45.73
- BRNS 57.82
- Support Level
- NSTS $11.90
- BRNS $0.96
- Resistance Level
- NSTS $12.39
- BRNS $1.04
- Average True Range (ATR)
- NSTS 0.13
- BRNS 0.06
- MACD
- NSTS -0.03
- BRNS 0.01
- Stochastic Oscillator
- NSTS 34.91
- BRNS 61.72
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.